Brief: Kaleido Biosciences Received Warning Letter From U.S. FDA

Kaleido Biosciences

03/09/2021 21:35

Sept 3 (Reuters) - Kaleido Biosciences Inc  KLDO.O :
    * KALEIDO BIOSCIENCES -  ON AUG. 27, RECEIVED WARNING LETTER
FROM
U.S. FDA FOR FAILURE TO SUBMIT IND PRIOR TO CONDUCTING TWO
STUDIES IN SUBJECTS WITH COVID-19
    * KALEIDO BIOSCIENCES - COORDINATING WITH FDA AND INTENDS TO
CONTINUE WITH ITS PLANS TO SUBMIT AN IND FOR KB109 IN SUPPORT OF
FUTURE CLINICAL RESEARCH
    * KALEIDO BIOSCIENCES, ON FDA  WARNING LETTER, SAYS THERE
WERE NO
FINDINGS RELATED TO CONDUCT OR OVERSIGHT OF TWO STUDIES IN
SUBJECTS WITH COVID-19
    * KALEIDO BIOSCIENCES, ON FDA  WARNING LETTER, SAYS THERE
WERE NO
FINDINGS RELATED TO DATA THAT WAS GENERATED FROM 2 STUDIES IN
SUBJECTS WITH COVID-19

Source text for Eikon: [https://bit.ly/2WQANiU]
Further company coverage:  KLDO.O 

 ((Reuters.Briefs@thomsonreuters.com;))